Pharmacogenetics, Pharmacogenomics and Population Admixture: Implications for Drug Development and Prescription

Nature Reviews Genetics - United Kingdom
doi 10.1038/nrg1722-c1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pharmacogenomics in Clinical Practice and Drug Development

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Pharmacogenomics in Clinical Practice and Drug Development

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Implications for Cancer Therapy

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2011English

Pharmacogenetics and Pharmacogenomics: A Bridge to Individualized Cancer Therapy

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2013English

Development of an Auto Monitoring System for the Drug Interaction on Prescription and Injectable Drug Prescription.

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2001English

Pharmacogenetics and Pharmacogenomics of Colorectal Cancer: Moving Towards Personalized Medicine

2012English

Pharmacogenomics and Pharmacogenetics of Hypertension: Update and Perspectives--The Adducin Paradigm

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2006English

Ontogeny and the Application of Pharmacogenomics to Pediatric Drug Development

Journal of Clinical Pharmacology
Pharmacology
2019English

Opportunities and Challenges of Implementing Pharmacogenomics in Cancer Drug Development

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy